Erste Asset Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Hold
14,000
﹤0.01% 531
2026
Q1
$404K Hold
14,000
﹤0.01% 528
2025
Q4
$464K Hold
14,000
﹤0.01% 507
2025
Q3
$482K Hold
14,000
﹤0.01% 484
2025
Q2
$392K Hold
14,000
﹤0.01% 666
2025
Q1
$356K Hold
14,000
﹤0.01% 449
2024
Q4
$382K Hold
14,000
﹤0.01% 459
2024
Q3
$410K Hold
14,000
﹤0.01% 455
2024
Q2
$352K Hold
14,000
﹤0.01% 446
2024
Q1
$461K Hold
14,000
0.01% 433
2023
Q4
$570K Buy
+14,000
New +$515K 0.01% 415
2021
Q4
Sell
-1,700
Closed -$88.7K 544
2021
Q3
$88.7K Hold
1,700
﹤0.01% 484
2021
Q2
$119K Hold
1,700
﹤0.01% 477
2021
Q1
$130K Hold
1,700
﹤0.01% 458
2020
Q4
$169K Sell
1,700
-5,500
-76% -$673K ﹤0.01% 442
2020
Q3
$1.02M Hold
7,200
0.03% 299
2020
Q2
$1.42M Hold
7,200
0.06% 267
2020
Q1
$1.37M Sell
7,200
-1,200
-14% -$258K 0.08% 221
2019
Q4
$1.76M Hold
8,400
0.08% 223
2019
Q3
$1.29M Hold
8,400
0.07% 231
2019
Q2
$1.07M Buy
+8,400
New +$997K 0.06% 252

Other funds holding LKFT

Erste Asset Management's LKFT Position: Q2 2026 in Review

Erste Asset Management held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q2 2026 at 14,000 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Erste Asset Management first reported a position in LKFT in Q2 2019 and has held it in 21 quarters since. The position peaked at $1.76M in Q4 2019. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Erste Asset Management held 14,000 shares of Lakefront Biotherapeutics American Depositary Shares worth $415K as of Q2 2026.
  • Erste Asset Management left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q2 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #531 holding.
  • Erste Asset Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and has held it in 21 quarters since.
  • Erste Asset Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.76M in Q4 2019.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.